Skip to main content
. 2021 Apr 27;10(5):526. doi: 10.3390/pathogens10050526

Figure 7.

Figure 7

Abundance of EVs in the plasma of HIV-1 patients. Plasmas from each group (HIV-1 negative, ART-naïve, ART-suppressed, and elite controllers) were pooled (n = 8), concentrated by ExoQuickTM, and resolved by ultracentrifugation on iodixanol velocity gradient. AChE activity was measured in each fraction. One-way ANOVA was used with the Tukey post-test. (** p < 0.01, *** p < 0.001).